Related Articles
Non‑conventional fotemustine schedule as second‑line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature
Multimodal treatment for local recurrent malignant gliomas: Resurgery and/or reirradiation followed by chemotherapy
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: Efficacy and safety in clinical practice
Immunoexpression of p62/SQSTM1/Sequestosome‑1 in human primary and recurrent IDH1/2 wild‑type glioblastoma: A pilot study
Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas